
Pharmaceutics Receives an Increased CiteScore of 12.5
We are pleased to share that Pharmaceutics (ISSN: 1999-4923) has received an increased CiteScore of 12.5 in June 2026. The CiteScore ranks the journal 12 out of 191 titles (Q1) in the “Pharmaceutical Science” category, an impressive achievement for a journal running in Volume 18.
You can find more statistics on our website. https://www.mdpi.com/journal/pharmaceutics/stats.
The current CiteScores measure the average number of citations within a journal over a four-year window (2022–2025). The Scopus database provides a comprehensive suite of metrics that support informed publishing strategies and research evaluation and enable benchmarking of journal performance.
This achievement reflects the collective efforts of our authors, reviewers, and editors. Together we will continue to track the progress of Pharmaceutics and its growing impact in pharmaceutical formulation, process development, drug delivery, pharmacokinetics, biopharmaceutics, pharmacogenetics, and interdisciplinary research involving, but not limited to, engineering, biomedical sciences, and cell biology.